SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
📖

Alzheimer's Disease Pyroptosis and Gasdermin Inhibitor Companies

wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-companies-ad-pyroptosis-gasdermin-i
Related Entities
companies-ad-pyroptosis-gasdermin-inhibitor-companies
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
482
Outgoing
492
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Linked Artifacts (573)
see_also📖BIIB080 (MAPTRx) Antisense Oligonucleotide for Alzheimer80%
see_also📖Ubiquitin-Proteasome System Dysfunction in Alzheimer's 80%
see_also📖Master Screening Study to Determine Individuals With Potenti80%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime80%
see_also📖KarXT (Xanomeline/Trospium) - Phase 3 for Alzheimer's D80%
see_also📖VY7523 Phase 1/2 Alzheimer's Disease Trial80%
see_also📖Probiotics in Mild Alzheimer's Disease (NCT06181513)80%
see_also📖Masupirdine for Agitation in Alzheimer's Disease (NCT0580%
see_also📖Nabilone for Agitation in Alzheimer's Disease (NCT0451680%
see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease80%
see_also📖DMB-I (Latrepirdine) Phase 3 (NCT07251023) — Alzheimer'80%
see_also📖BMS-986368 Phase 2 - Agitation in Alzheimer's Disease80%
related🧪LRP1-Dependent Tau Uptake Disruption80%
see_also📖BMS-986446 Phase 2 Trial for Early Alzheimer's Disease80%
see_also📖Tear Film Biomarkers in Alzheimer's Disease80%
see_also📖Tau Kinase Signaling Cascade in Alzheimer's Disease80%
see_also📖Sleep Biomarkers for Alzheimer's Disease80%
see_also📖TRAILBLAZER-ALZ 3 (NCT05026866) — Donanemab for Preclinical 80%
see_also📖APOE4 and Alzheimer's Disease Risk80%
related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation80%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy80%
see_also📖Olfactory Biomarkers for Alzheimer's Disease80%
see_also📖NLRP3 Inflammasome Pathway in Alzheimer's Disease80%
see_also📖ONO-2020 for Alzheimer's Disease (NCT06881836)80%
see_also📖Neuroinflammation Hypothesis in Alzheimer's Disease80%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 80%
see_also📖NCT06582706: Nicotinic Acid for Alzheimer's Disease80%
see_also📖SToP-AD: Suvorexant for Alzheimer's Disease Prevention80%
see_also📖ExPlas — Exercise Plasma Transfusion for Alzheimer's Di80%
see_also📖Sporadic Alzheimer's Disease Pathway80%
see_also📖SNIFF-Combo: Intranasal Insulin + Empagliflozin for Alzheime80%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI80%
related🧪APOE Isoform Expression Across Glial Subtypes80%
see_also📖Endolysosomal Pathway in Alzheimer's Disease80%
see_also📖Mitochondrial Dysfunction in Alzheimer's Disease Pathwa80%
related🧪VCP-Mediated Autophagy Enhancement80%
see_also📖ACP-204 for Alzheimer's Disease Psychosis (NCT06159673)80%
see_also📖Glymphatic System in Alzheimer's Disease80%
see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime80%
see_also📖SHR-1707 for Alzheimer's Disease (NCT06199037)80%
see_also📖MK-2214 for Early Alzheimer's Disease80%
see_also📖EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer80%
see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease80%
see_also📖IGC-AD1 for Agitation in Alzheimer's Disease (NCT05543680%
see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058280%
related🧪Trans-Synaptic Adhesion Molecule Modulation80%
see_also📖Synaptic Loss in Alzheimer's Disease Pathway80%
see_also📖ITI-1284 for Alzheimer's Disease Psychosis (NCT0654083380%
see_also📖NAB-IT: Nabilone for Agitation in Alzheimer's Disease80%
see_also📖Metal Ion Homeostasis in Alzheimer's Disease80%
see_also📖GFAP in Alzheimer's Disease80%
see_also📖Neurovascular Dysfunction in Alzheimer's Disease: Integ80%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI80%
see_also📖Masupirdine for Alzheimer's Disease Agitation80%
see_also📖Centella asiatica Phase 1 Trial for Alzheimer's Disease80%
see_also📖Sex-Specific Mechanisms in Alzheimer's Disease80%
related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli80%
see_also📖Plasma Phospho-Tau Ratio Diagnostic Panel for Alzheimer'80%
see_also📖Piromelatine 20 mg for Mild Dementia Due to Alzheimer's80%
see_also📖NCT06803823 - ONO-2020 for Agitation in Alzheimer's Dis80%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St80%
see_also📖EEG Biomarkers for Alzheimer's Disease80%
see_also📖Dried Blood Spot Biomarker Test for Alzheimer's Disease80%
see_also📖Biogen Alzheimer's Disease Phase 2 Trial (NCT05399888)80%
see_also📖EEG Microstates in Alzheimer's Disease80%
see_also📖Neuroinflammation in Alzheimer's Disease80%
see_also📖Vascular Dementia Mechanisms — Overlap with Alzheimer's80%
see_also📖Tau Kinase-Phosphatase Balance in Alzheimer's Disease80%
see_also📖CD33 Siglec Receptor Dysfunction Alzheimer's Disease Ca80%
see_also📖Exciva Alzheimer's Disease Phase 2/3 Trial80%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0680%
see_also📖Diffuse Amyloid Deposits in Alzheimer's Disease80%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna80%
see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease80%
see_also📖The Alzheimer's Disease Tau Platform Clinical Trial (NC80%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0680%
see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di80%
see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06780%
see_also📖Ozanimod for Alzheimer's Disease (NCT06862960)80%
see_also📖X/T + X-EC + Lecanemab Phase 2 (NCT07212062) — Alzheimer80%
see_also📖Foralumab Phase 2 Trial for Alzheimer's Disease80%
see_also📖GV1001 for Moderate to Severe Alzheimer's Disease (NCT080%
see_also📖Alzheimer's Disease Biomarkers80%
see_also📖Guanfacine NorAD - Phase 3 Trial for Alzheimer's Diseas80%
see_also📖LEAF Trial - THC+CBD for Alzheimer's Disease Agitation 80%
see_also📖Ocular Fluid Biomarkers for Alzheimer's Disease80%
see_also📖NCT03875638 - Levetiracetam for Alzheimer's Disease80%
see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh80%
see_also📖Senicapoc Alzheimer's Disease Trial - NCT0480424180%
see_also📖Alzheimer's Disease Mechanism Index80%
see_also📖Locus Coeruleus Degeneration in Alzheimer's Disease80%
see_also📖NCT07262645: Near-Infrared Light Therapy for Mild-Moderate A80%
see_also📖CBD (Cannabidiol) for Alzheimer's Disease Agitation - N80%
see_also📖MAR Polypill for Alzheimer's Disease (NCT06597058)80%
see_also📖Neurogranin - Alzheimer's Disease Biomarker80%
see_also📖Salivary Biomarkers for Alzheimer's Disease80%
related🧪Complement C1QA Spatial Gradient in Cortical Layers80%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t80%
related🧪HSP90-Tau Disaggregation Complex Enhancement80%
see_also📖Gait Biomarkers for Alzheimer's Disease80%
see_also📖Cholinergic System Degeneration in Alzheimer's Disease80%
see_also📖ASN90 Phase 2 Trial - Early Alzheimer's Disease (NCT05680%
related🧪Extracellular Vesicle Biogenesis Modulation80%
see_also📖Recombinant Human Serum Albumin for Alzheimer's Disease80%
see_also📖LHP588: P. gingivalis Targeting for Alzheimer's Disease80%
see_also📖Siponimod for Alzheimer's Disease (NCT06639282)80%
see_also📖Digital Biomarkers for Alzheimer's Disease80%
related🧪Prefrontal sensory gating circuit restoration via PV interne80%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation80%
see_also📖Fasudil for Early Alzheimer's Disease (FEAD) - NCT0636280%
see_also📖Escitalopram for Agitation in Alzheimer's Disease (NCT080%
see_also📖NRTIs for Alzheimer's Disease - Phase 1 (NCT07210528)80%
see_also📖Latrepirdine (DMB-I) Phase 3 Trial for Alzheimer's Dise80%
see_also📖Synaptic Biomarkers for Alzheimer's Disease80%
see_also📖ASL Perfusion Biomarkers for Alzheimer's Disease80%
see_also📖Inflammatory Biomarkers in Alzheimer's Disease80%
see_also📖DTI Biomarkers for Alzheimer's Disease80%
see_also📖APOE Lipid Metabolism Pathway in Alzheimer's Disease80%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia80%
see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers80%
see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451680%
see_also📖Eye-Tracking Digital Markers in Alzheimer's Disease80%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro80%
see_also📖PLX5622 CSF1R Inhibitor Trial in Early Alzheimer's Dise80%
related🧪TREM2-mediated microglial tau clearance enhancement80%
related🧪Synaptic Vesicle Tau Capture Inhibition80%
see_also📖NRTIs for Alzheimer's Disease: Targeting Type-I Interfe80%
see_also📖TRAP-AD: Transcranial Photobiomodulation for Alzheimer'80%
see_also📖[F-18]Flornaptitril PET - Phase 3 for Alzheimer's Disea80%
related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK80%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro72%
related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli72%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia72%
related🧪APOE Isoform Expression Across Glial Subtypes72%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation72%
related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK72%
related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation72%
related🧪Complement C1QA Spatial Gradient in Cortical Layers72%
mentions🧪Lipid Droplet Dynamics as Phenotype Switches70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
mentions🧪Purinergic Signaling Polarization Control70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
mentions🧪Mechanosensitive Ion Channel Reprogramming70%
related🧪Lipid Droplet Dynamics as Phenotype Switches63%
related🧪Purinergic Signaling Polarization Control63%
related🧪Mechanosensitive Ion Channel Reprogramming63%
related🧫Anti-Tau Immunotherapy Dosing Optimization60%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD60%
related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa60%
related🧫ApoE4 Function in Alzheimer's Disease60%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr60%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia60%
related🧫Prion Strain Diversity and Selective Vulnerability60%
related🧫Tau ASO Therapy60%
related🧫Vascular Contribution to Alzheimer's Disease — Beyond A60%
related🧫Blood-Based Biomarker Panel for Early AD Detection60%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti60%
related🧫Viral Infections and Alzheimer's Disease — causal mecha60%
related🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 60%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease60%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi60%
related🧫Sleep Disruption and Alzheimer's Disease — mechanism an60%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 60%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress60%
related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease60%
related🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech60%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration60%
related🧫Experiment: Autoimmune Hypothesis Testing in AD60%
related🧫Experiment Validation: In vitro ThT Assay60%
related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M60%
related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera60%
related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#60%
related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise60%
related🧫Gap Junction Dysfunction Validation in Parkinson's Dise60%
related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#60%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation60%
related🧫4R-Tau Targeting Therapies for PSP and CBS60%
related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?60%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and60%
related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas60%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation60%
related🧫Normal Aging to Alzheimer's Disease Transition Trigger 60%
related🧫Proposed experiment from debate on Synaptic pruning by micro60%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD60%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 60%
related🧫s:** - Test whether HCN1 knockout specifically in EC layer I60%
related🧫tACS Connectivity Trial in Early Alzheimer's60%
related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau60%
related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol60%
related🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis60%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera60%
related🧫Microglial TREM2 Agonist In Vivo Efficacy60%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap60%
see_also📖ABCA7 Lipid Transport and Microglial Phagocytosis AD Causal 55%
see_also📖Endosomal Sorting Defects in Neurodegeneration55%
see_also📖Neural Circuit Disruption in Neurodegeneration55%
see_also📖Senescent Cell Clearance in Neurodegeneration55%
see_also📖Blood-Brain Barrier and Neuroimmune Interface in CBS/PSP55%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration55%
related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise54%
related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas54%
related🧫Sleep Disruption and Alzheimer's Disease — mechanism an54%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi54%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress54%
related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?54%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr54%
related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa54%
related🧫Blood-Based Biomarker Panel for Early AD Detection54%
related🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 54%
related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol54%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and54%
related🧫4R-Tau Targeting Therapies for PSP and CBS54%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap54%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 54%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration54%
related🧫Proposed experiment from debate on Synaptic pruning by micro54%
related🧫Gap Junction Dysfunction Validation in Parkinson's Dise54%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti54%
related🧫Anti-Tau Immunotherapy Dosing Optimization54%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation54%
related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#54%
related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera54%
related🧫s:** - Test whether HCN1 knockout specifically in EC layer I54%
related🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis54%
related🧫Vascular Contribution to Alzheimer's Disease — Beyond A54%
related🧫tACS Connectivity Trial in Early Alzheimer's54%
related🧫Prion Strain Diversity and Selective Vulnerability54%
related🧫Microglial TREM2 Agonist In Vivo Efficacy54%
related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease54%
related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#54%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease54%
related🧫Experiment Validation: In vitro ThT Assay54%
related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M54%
related🧫Normal Aging to Alzheimer's Disease Transition Trigger 54%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation54%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia54%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD54%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 54%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD54%
related🧫Experiment: Autoimmune Hypothesis Testing in AD54%
related🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech54%
related🧫Viral Infections and Alzheimer's Disease — causal mecha54%
related🧫ApoE4 Function in Alzheimer's Disease54%
related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau54%
related🧫Tau ASO Therapy54%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera54%
mentions🧪HSP90-Tau Disaggregation Complex Enhancement50%
see_also📖C9orf72 Repeat Expansions in CBS and PSP50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
see_also📖Therapeutic Targets in Neurodegeneration50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Investigate prion-like spreading of tau pathology through co50%
see_also📖Down Syndrome Neurodegeneration Pathway50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration50%
related🔬Investigate prion-like spreading of tau pathology through co50%
see_also📖Tau Seeding and Propagation Pathway50%
see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration50%
see_also📖Myoclonus and Cortical Hyperexcitability in Corticobasal Syn50%
mentions🧪Trans-Synaptic Adhesion Molecule Modulation50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
see_also📖Sex Differences in Neurodegeneration50%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration50%
mentions🧪Synaptic Vesicle Tau Capture Inhibition50%
see_also📖Neuroinflammation in Parkinson's Disease Dementia and D50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
see_also📖Convergent Pathways in Neurodegeneration50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
see_also📖Advanced Proteolysis and Ubiquitin System Targeting in CBS/P50%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration50%
see_also📖Shared Mechanisms Between Alzheimer and Parkinson Disease50%
see_also📖PPAR Signaling Pathway in Neurodegeneration50%
see_also📖COVID-19 Neurodegeneration Mechanism50%
see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
mentions🧪VCP-Mediated Autophagy Enhancement50%
see_also📖Axon Guidance Pathways in Neurodegeneration50%
see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration50%
see_also📖mTOR Signaling in Autophagy and Lysosomal Function50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
see_also📖FTLD-TDP Subtypes and Mechanisms50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
mentions🧪Extracellular Vesicle Biogenesis Modulation50%
mentions🧪LRP1-Dependent Tau Uptake Disruption50%
related🔬What are the most promising therapeutic strategies for targe50%
see_also📖Systemic Infection and Tau Pathology Acceleration50%
see_also📖Neurovascular Unit Dysfunction in Neurodegeneration50%
see_also📖Neuroresilience Mechanisms and Evidence50%
see_also📖HLA Haplotypes and Neuroinflammatory Profiles in PSP50%
see_also📖Retinal Degeneration Pathway in Neurodegeneration50%
see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration50%
see_also📖RNA-Targeted Therapies in Neurodegeneration50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
mentions🧪Prefrontal sensory gating circuit restoration via PV interne50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
see_also📖Galectin-3 Mechanism in Neurodegeneration50%
see_also📖Microglial Priming Pathway in Neurodegeneration50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
see_also📖IL-1 Signaling Pathway in Neurodegeneration50%
see_also📖Blood-Brain Barrier Dysfunction and Therapeutic Delivery for50%
see_also📖Antibody Therapy in Neurodegeneration50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
see_also📖Dystrophic Neurites in Neurodegeneration50%
see_also📖HMGB1 Signaling in Neurodegeneration50%
see_also📖Synaptic Loss and Dysfunction Pathway50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%
see_also📖Lipid Metabolism Dysregulation in Neurodegeneration50%
see_also📖Investment Landscape: Frontotemporal Dementia45%
see_also📖Pupillometry and Chromatic Pupillometry in Corticobasal Synd45%
see_also📖Glymphatic Clearance Hypothesis — Impaired Aβ and Tau Remova45%
see_also📖Environmental Toxins and Parkinson's Risk45%
see_also📖Digital Therapeutic Platform for Swallowing and Drooling Pro45%
see_also📖Ghrelin Signaling Pathway in Neurodegeneration45%
see_also📖Japanese and German Case Series in Corticobasal Degeneration45%
see_also📖Digital Phenotyping in Neurodegeneration45%
see_also📖LRRK2 Gene Variants and Mutations45%
see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration45%
see_also📖Postural Dysfunction and Abnormalities in Corticobasal Syndr45%
see_also📖Autosis Pathway in Neurodegeneration45%
see_also📖Whole-Body Photobiomodulation for Motor and Cognitive Change45%
see_also📖A Phase III, Randomized, Double-Blind, Placebo-Controlled, M45%
see_also📖Caregiver Burden and Support in Corticobasal Syndrome45%
see_also📖LRRK2 Kinase Activation and Endolysosomal Dysfunction in Par45%
see_also📖ALS Therapeutic Landscape — Programs by Phase and Modality45%
see_also📖epigenetics-neurodegeneration45%
see_also📖Cortical Involvement and Neurodegeneration in Progressive Su45%
see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a45%
see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio45%
see_also📖VEGF and Angiogenesis Dysregulation in CBS/PSP45%
see_also📖GDF15/GDF11 Signaling in Neurodegeneration45%
see_also📖Dysphagia and Nutritional Management in Corticobasal Syndrom45%
see_also📖Copper Homeostasis in Neurodegeneration45%
see_also📖Utilisation of Health Services and Quality of Life in Atypic45%
see_also📖Homocysteine Neurotoxicity and Neurodegeneration45%
see_also📖Purinergic Signaling in Neurodegeneration45%
see_also📖Polygenic Risk Score Integration Panel for Alzheimer's 45%
see_also📖Kidney-Brain Neurodegeneration Axis45%
see_also📖Nutritional Support and Dietary Interventions in Corticobasa45%
see_also📖Prion Protein Metabolism in Neurodegeneration45%
see_also📖Cognitive Reserve and Resilience in Neurodegeneration45%
see_also📖TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain45%
see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration45%
see_also📖MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acid45%
see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl45%
see_also📖Prion-Like Spread in Neurodegeneration45%
see_also📖Clinical Efficacy and Mechanism of tDCS for Dysphagia in Par45%
see_also📖Pupillary and Visual Dysfunction in Progressive Supranuclear45%
see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr45%
see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas45%
see_also📖PI-2620 Tau PET Phase 3 (NCT05456503) - FTLD and Atypical AD45%
see_also📖IGF-1 Signaling Pathway in Neurodegeneration45%
see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration45%
see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration45%
see_also📖Multi-Analyte Biomarker Panel for Parkinson's Disease D45%
see_also📖Clostridium Butyricum for Motor and Non-motor Symptoms in Pa45%
see_also📖RNA Splicing in Neurodegeneration45%
see_also📖Investment Landscape: Parkinson's Disease45%
see_also📖Economic Burden — Neurodegeneration45%
see_also📖Prognostic Biomarkers in Neurodegeneration45%
see_also📖Voice and Speech in Corticobasal Syndrome45%
see_also📖Protein Aggregation Comparison in Neurodegeneration45%
see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati45%
see_also📖Manganese-Related Neurodegeneration (Manganism)45%
see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration45%
see_also📖Advanced Glycation End Products in Neurodegeneration45%
see_also📖Disease Progression & Staging in Neurodegeneration45%
see_also📖CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subc45%
see_also📖NRF2 Signaling Pathway in Neurodegeneration45%
see_also📖PSP Tau Propagation and Spreading Mechanisms45%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)45%
see_also📖Iron and Neuromelanin Accumulation in PSP45%
see_also📖Vocational Rehabilitation and Driving in Corticobasal Syndro45%
see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M45%
see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 45%
see_also📖Cell-Free DNA Biomarkers in Neurodegeneration45%
see_also📖Quality of Life and Caregiver Burden in PSP (NCT03638505)45%
see_also📖Clinical Phenotypes and Subtypes of Corticobasal Syndrome45%
see_also📖Glycosylation in Neurodegeneration45%
see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration45%
see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)45%
see_also📖AAIC 2026: Tau-PET Imaging and Fluid Biomarker Integration45%
see_also📖Sleep Architecture Changes in CBS and PSP45%
see_also📖PLA2G6-Associated Neurodegeneration (PLAN)45%
see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N45%
see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration45%
see_also📖PKR Pathway in Neurodegeneration45%
see_also📖Neuroimaging Biomarkers for Neurodegeneration45%
see_also📖India Neurodegeneration Epidemiology45%
see_also📖Endocannabinoid System in Neurodegeneration45%
see_also📖Alpha-Synuclein PET Imaging and Biomarker Advances45%
see_also📖p-Tau Biomarker in Immunoglobulin Light Chain and Transthyre45%
see_also📖Integrated Stress Response in Neurodegeneration45%
see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc45%
see_also📖alexander-disease45%
see_also📖PSP Weight Loss and Cachexia45%
see_also📖mitochondrial-dysfunction-neurodegeneration-comparison45%
see_also📖P-Body (Processing Body) Pathway in Neurodegeneration45%
see_also📖Neuropil Threads in Neurodegeneration45%
see_also📖Nitric Oxide Signaling in Neurodegeneration45%
see_also📖Quality of Life and Caregiver Burden in Progressive Supranuc45%
see_also📖Orexin Signaling in Neurodegeneration45%
see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration45%
see_also📖Parthanatos in Neurodegeneration45%
see_also📖Pseudobulbar Affect and Emotional Lability in Corticobasal S45%
see_also📖Sialorrhea and Drooling in Corticobasal Syndrome45%
see_also📖European Neurodegeneration Epidemiology45%
see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen45%
see_also📖Speech and Voice Disorders in PSP45%
see_also📖Glymphatic and Vascular Clearance Dysfunction in 4R-Tauopath45%
see_also📖Ribosome Dysfunction in Neurodegeneration45%
see_also📖A 6-month & 18-month Prospective, Randomized, Placebo-co45%
see_also📖US Neurodegeneration Epidemiology45%
see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)45%
see_also📖Braak Staging and Tau Propagation Pathway45%
see_also📖Metabolic Dysfunction and Insulin Resistance in Progressive 45%
see_also📖Multimodal Diagnostic Algorithm for CBS and PSP45%
see_also📖Diffusion MRI (DTI) in Neurodegeneration45%
see_also📖Gait and Upper Limb Evaluation in PSP (NCT07136844)45%
see_also📖Mitochondrial Fusion in Neurodegeneration45%
see_also📖CNversyt and Megan Rodden ALS Trials45%
see_also📖Metal Homeostasis Dysregulation in Neurodegeneration45%
see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and45%
see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration45%
see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration45%
see_also📖Long-term Effects of Hearing Intervention on Brain Health in45%
see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio45%
see_also📖Alpha-Synuclein Seeding Assays (RT-QuIC and PMCA)45%
see_also📖Pericyte Loss in Neurodegeneration45%
see_also📖interleukin-6-signaling-neurodegeneration45%
see_also📖Hippocampal Neurogenesis in Neurodegeneration45%
see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration45%
see_also📖China Neurodegeneration Epidemiology45%
see_also📖Neurotensin Signaling in Neurodegeneration45%
see_also📖Mirror Therapy and Sensory Re-education in Corticobasal Synd45%
see_also📖Social Behaviors and Quality of Life in Parkinson's Dis45%
see_also📖Short Chain Fatty Acids in Neurodegeneration45%
see_also📖Investment Landscape: ALS45%
see_also📖Synaptic Biomarkers in Neurodegeneration45%
see_also📖R-Loop Stress in Neurodegeneration45%
see_also📖GDNF Signaling Pathway in Neurodegeneration45%
see_also📖Healthcare Economics and Cost of Illness in Progressive Supr45%
see_also📖SUMOylation in Neurodegeneration45%
see_also📖Gait and Balance Disorders in Progressive Supranuclear Palsy45%
see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat45%
see_also📖mTOR Signaling Pathway in Neurodegeneration45%
see_also📖Computational Disease Models for Neurodegeneration45%
see_also📖ALS Biomarkers and Disease Monitoring45%
see_also📖Prion Diseases in Neurodegeneration45%
see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 45%
see_also📖PSP and Idiopathic Normal Pressure Hydrocephalus: Clinical O45%
see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain45%
see_also📖Potential Impact Measures — Neurodegeneration45%
see_also📖Neural Circuits in Neurodegeneration45%
see_also📖Sigma-1 Receptor Signaling in Neurodegeneration45%
see_also📖Callosal Disconnection and Interhemispheric Dysfunction in C45%
see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration45%
see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 45%
see_also📖Cognitive and Speech Rehabilitation in CBS (NCT05823421)45%
see_also📖Imaging Biomarkers for Corticobasal Syndrome and Progressive45%
see_also📖Familial vs Sporadic Neurodegeneration Comparison45%
see_also📖Simultanagnosia and Balint's Syndrome in Corticobasal S45%
see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration45%
see_also📖T-Cell Dysfunction in Neurodegeneration45%
see_also📖Sleep Dysfunction in Neurodegeneration45%
see_also📖Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pi45%
see_also📖NF-kB Signaling Pathway in Neurodegeneration45%
see_also📖First-in-Human 4R Tau Ligand Study in PSP (NCT07348276)45%
see_also📖Noradrenergic Signaling Pathway in Neurodegeneration45%
see_also📖S100 Protein Signaling Pathway in Neurodegeneration45%
see_also📖HIV-Associated Neurocognitive Disorders (HAND)45%
see_also📖FTDP-17 Clinical Phenotypes and Disease Progression45%
see_also📖Silymarin for Neuroprotection and Symptom Management in Park45%
see_also📖acetylcholine-signaling-neurodegeneration45%
see_also📖Jervell and Lange-Nielsen Syndrome45%
see_also📖IL-6 (Interleukin-6) in Neurodegeneration45%
see_also📖Metal Homeostasis in Neurodegeneration45%
see_also📖Lipid Dysregulation in Neurodegeneration45%
see_also📖Alexander Disease Genetic Variants45%
see_also📖NLRP3 Inhibitors in Parkinson's Disease: Research and C45%
see_also📖Protein Aggregation Seeds in Neurodegeneration45%
see_also📖Molecular Chaperones in Neurodegeneration45%
see_also📖Serotonergic Dysfunction in Neurodegeneration45%
see_also📖ATP13A9 and Parkinson's Disease45%
see_also📖Progesterone Signaling Pathway in Neurodegeneration45%
see_also📖Safety and Clinical Outcomes Study: Amniotic and Umbilical C45%
see_also📖Global Neurodegeneration Epidemiology45%
see_also📖synaptic-vesicle-cycling-neurodegeneration45%
see_also📖Speech Therapy and Communication Aids in Corticobasal Syndro45%
see_also📖Amylin Signaling in Neurodegeneration45%
see_also📖Speech and Language Deficits in Corticobasal Syndrome45%
see_also📖DALY Methodology — Neurodegeneration45%
see_also📖Phase 3 Study to Compare the Efficacy and Safety of Masitini45%
see_also📖SNCA Gene Variants and Mutations45%
see_also📖GBA Brain Molecular Imaging and Blood Biomarkers for Precisi45%
see_also📖mTOR Signaling in Neurodegeneration45%
see_also📖Caregiver Support and Palliative Care in Atypical [Parkinson45%
see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration45%
see_also📖BLAAC PD - Black and African Americans Connections to PD (NC45%
see_also📖GBA Glucocerebrosidase Dysfunction and Parkinson's Dise45%
see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 45%
see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener45%
see_also📖RAN Translation in Neurodegeneration45%
see_also📖Vagus Nerve Pathway in Neurodegeneration45%
see_also📖Hereditary Sensory and Autonomic Neuropathy (HSAN)45%
see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration45%
see_also📖Liquid Biopsy in Neurodegeneration45%
see_also📖MicroRNA Dysfunction in Neurodegeneration45%
see_also📖Histone Modification Pathways in Neurodegeneration45%
see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial45%
see_also📖MSA Clinical Features and Diagnosis45%
see_also📖Paraptosis in Neurodegeneration45%
see_also📖Paranodal Dysfunction in Neurodegeneration45%
see_also📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy45%
see_also📖Gait Analysis Parameter and Upper Limb Evaluation in Neurolo45%
see_also📖PSP Liquid-Liquid Phase Separation and Biomolecular Condensa45%
see_also📖Pesticides and Parkinson Disease (Pest-PD) — NCT0642031045%
see_also📖PCDH19-Related Epilepsy (EFMR) — Preclinical Gene Therapy Pr45%
see_also📖Physical and Occupational Therapy in Corticobasal Syndrome45%
see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration45%
see_also📖A Multicenter, Phase III, Randomized, Double Blind, Placebo-45%
see_also📖CBS/PSP Panxoneopathy and Membrane Biology45%
see_also📖Metabolomic Biomarkers in Neurodegeneration45%
see_also📖Somatic Mutations and Brain Mosaicism45%
see_also📖Japan Neurodegeneration Epidemiology45%
see_also📖Tertiary Lymphoid Organs in Neurodegeneration45%
see_also📖Cholinergic System Dysfunction in Neurodegeneration45%
see_also📖CaMKII Signaling Pathway in Neurodegeneration45%
see_also📖FA2H-Associated Neurodegeneration Pathway45%
see_also📖Natural History and Prognosis of Corticobasal Syndrome45%
see_also📖A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-C45%
see_also📖A Phase 3, Randomized, Double-blind, Placebo-controlled, Par45%
see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration45%
see_also📖Exosomal miR-155 in Neurodegeneration45%
see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration45%
see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration45%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)45%
see_also📖PSP Lysosomal Dysfunction and Autophagy Impairment45%
see_also📖Neuronal Hyperexcitability in Neurodegeneration45%
see_also📖Gangliosides in Neurodegeneration45%
see_also📖Sleep Disorders in Neurodegeneration45%
see_also📖Exosomal Biomarkers in Neurodegeneration45%
see_also📖Glial Tau Pathology in PSP and CBD45%
see_also📖Endothelin Signaling Pathway in Neurodegeneration45%
see_also📖Neuropeptide Y Signaling in Neurodegeneration45%
see_also📖Sandhoff Disease45%
see_also📖Hemiballismus and Hemichorea in Corticobasal Syndrome45%
see_also📖Investment Landscape: Huntington's Disease45%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
related🧪TREM2-mediated microglial tau clearance enhancement40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
related🧪Extracellular Vesicle Biogenesis Modulation40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
related🧪VCP-Mediated Autophagy Enhancement40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
related🧪HSP90-Tau Disaggregation Complex Enhancement40%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
related🧪Trans-Synaptic Adhesion Molecule Modulation40%
related🧪Synaptic Vesicle Tau Capture Inhibition40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
related🧪Prefrontal sensory gating circuit restoration via PV interne40%
related🧪LRP1-Dependent Tau Uptake Disruption40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub